Sphere Fluidics, announced the launch of Cyto-Mine ® Chroma and the opening of its ... the Company will collaborate closely with forward-thinking customers to drive innovation and inform the ...

Future studies will need to investigate in detail the mechanisms by which colforsin daropate disrupts ovarian cancer sphere adhesion." More information: Matthew J. Knarr et al, Repurposing ...

The findings showed that the administration of UDCA led to a reduction in intracellular ROS levels within the pancreatic cancer cells. Moreover, UDCA was observed to decrease both the phosphorylation ...

Through the program, the Company will collaborate closely with forward-thinking customers to drive innovation and inform the development of future applications and assays on the platform.

CAMBRIDGE, England--(BUSINESS WIRE)--Sphere Fluidics ... innovation and inform the development of future applications and assays on the platform. Offering enhanced capabilities, including ...

School of Basic Medical Science, Xi’an Key Laboratory of Pathogenic Microorganism and Tumor Immunity, Xi’an Medical University, Xi’an 710021, China School of Biotechnology and Health Sciences, Wuyi ...

Researchers invited to gain early access to next-generation platform to optimize functional single-cell analysis workflows across expanded applications in life science R&D CAMBRIDGE, ...

Researchers invited to gain early access to next-generation platform to optimize functional single-cell analysis workflows across expanded applications in life science R&D Cyto-Mine Chroma represents ...

A brain tumor is a mass of abnormal cells that grow in the brain. Brain tumors can be benign (non-cancerous) or malignant (cancerous) and can start anywhere in the brain. Malignant tumors grow rapidly ...